Clinical Trial Update: Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating obeticholic acid for Familial Partial Lipodystrophy has completed. Results were posted in December 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Partial Lipodystrophy

Drugs mentioned

• Obeticholic acid (Ocaliva) (obeticholic acid)

Snippet

Sponsor: Abhimanyu Garg | Conditions: Familial Partial Lipodystrophy | Phase 2 | Status: COMPLETED | Results posted: 2023-12-13